What is the clinical evidence from this study?

Study design: Review. Population: Obesity and Cardiovascular Risk Factors. Intervention: Bariatric Surgery vs. Conventional medical management.

April 5, 2026Open Access

Impact of Bariatric Surgery on Cardiovascular Risk Factors: A Narrative Review

Key Result

Bariatric surgery reduces cardiovascular mortality by approximately 30% compared with matched obese controls receiving usual pharmacological care.

Key Points

This review aims to summarize the effects of bariatric surgery on cardiovascular risk factors and explore underlying mechanisms.
Narrative review of existing literature on bariatric surgery and cardiovascular outcomes.
Discussion of various types of bariatric procedures and their implications for cardiovascular health.
Examination of metabolic and physiological mechanisms involved post-surgery.
Bariatric surgery leads to significant improvements in glycemic control and diabetes remission.
Patients experience considerable reductions in blood pressure and favorable changes in lipid profiles.
There is a substantial reduction in major adverse cardiovascular events and mortality among surgically treated patients.

Structured PICO

Does bariatric surgery reduce cardiovascular risk factors and major adverse cardiovascular events in individuals with obesity?

Population

Individuals with obesity

Intervention

Bariatric surgery (including sleeve gastrectomy, Roux-en-Y gastric bypass, adjustable gastric banding, and biliopancreatic diversion)

Comparator

Conventional medical management or matched nonsurgical controls

Outcome

Cardiovascular risk factors (glycemic control, blood pressure, lipid profiles) and major adverse cardiovascular events (MACE)

Bariatric surgery serves as an effective metabolic intervention that significantly improves cardiovascular risk factors and reduces long-term cardiovascular morbidity and mortality in patients with obesity.

Limitations

Much of the data is derived from observational cohort studies and registry-based analyses rather than randomized controlled trials, leaving potential for residual confounding.
Heterogeneity in study populations, surgical techniques, and outcome definitions limits direct comparison across studies.
Long-term follow-up data remain limited for certain procedures, particularly Biliopancreatic Diversion.
Disparities in access to bariatric surgery and underrepresentation of certain populations limit the generalizability of findings.

Abstract

Obesity can be considered a global pandemic, already affecting a considerable and increasing number of adults. It has been described as one of the most important preventable causes of cardiovascular morbidity and mortality. Obesity accelerates the development and progression of cardiovascular disease through its strong correlations with hypertension, dyslipidemia, insulin resistance, type 2 diabetes mellitus, systemic inflammation, and adverse cardiac remodeling. Bariatric surgery, the current most effective long-term treatment for obesity, has increasingly been recognized as a metabolic intervention with benefits to the cardiovascular system. Accumulating evidence indicates that surgical weight loss is accompanied by rapid and sustained improvements in glycemic control, with high rates of diabetes remission, significant reductions in blood pressure, and favorable changes in lipid profiles. In parallel, bariatric procedures lead to attenuation of chronic low-grade inflammation, improvement in endothelial function, and regression of obesity-related cardiac structural abnormalities. Studies demonstrate a substantial reduction in major adverse cardiovascular events and cardiovascular mortality among surgically treated patients compared with matched nonsurgical controls. These benefits may result from both weight-dependent and weight-independent mechanisms, including alterations in gut hormones, bile acid metabolism, insulin sensitivity, and neurohormonal regulation. This narrative review aims to present the current evidence on the effects of bariatric surgery on established cardiovascular risk factors, discuss potential mechanistic pathways, types of bariatric procedures and emphasize the role of metabolic surgery as an effective strategy for reducing cardiovascular risk in individuals with obesity.

Bookmark

View Full Paper